Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of anagliptin + metformin on postprandial triglycerides in type 2 diabetes (TIME-TG)
jRCTs051200098Completed
- Sponsor
- Sanwa Kagaku Kenkyusho Co., Ltd.
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of anagliptin and metformin in type 2 diabetes mellitus (T2DM) and hypertriglyceridemia, sponsored by Sanwa Kagaku Kenkyusho Co., Ltd. Primary endpoint: Change in AUC of postprandial triglyceride during 4 hours after cookie loading test. Started Jul 2021; status: completed.
02
Drugs
anagliptinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)hypertriglyceridemia
Beyond the preview
Go deeper on jRCTs051200098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051200098.